Mixed ductal-endocrine carcinoma derived from Intraductal Papillary Mucinous Neoplasm (IPMN) of the pancreas identified by human Telomerase Reverse Transcriptase (hTERT) expression

Journal of Surgical Oncology

Volumn 97, Issue 5, 2008, Pages 469-475

  Hashimoto, Yasushi ^a   Murakami, Yoshiaki ^a   Uemura, Kenichiro ^a   Hayashidani, Yasuo ^a   Sudo, Takeshi ^a   Ohge, Hiroki ^a   Sueda, Taijiro ^a   Shimamoto, Fumio ^b   Hiyama, Eiso ^a,c  

^a HIROSHIMA UNIVERSITY   (Japan)

^b PREFECTURAL UNIVERSITY OF HIROSHIMA   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Human telomerase reverse transcriptase (hTERT); Immunohistochemistry; Intraductal papillary mucinous neoplasm (IPMN); Mixed ductal endocrine carcinoma; Telomerase activity

Indexed keywords

TELOMERASE REVERSE TRANSCRIPTASE;

AGED; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DISEASE COURSE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ASSAY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MALE; MIXED DUCTAL ENDOCRINE CARCINOMA; MIXED TUMOR; PANCREAS CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; TISSUE SECTION;

ADENOCARCINOMA, MUCINOUS; AGED; CARCINOMA, ISLET CELL; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; NEOPLASMS, SECOND PRIMARY; PANCREATIC NEOPLASMS; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 41549112949     PISSN: 00224790     EISSN: 10969098     Source Type: Journal    
DOI: 10.1002/jso.20959     Document Type: Article

References (27)

1. Longnecker DS, Adsay NV, Fernandez-del Castillo C, et al.: Histopathological diagnosis of pancreatic intraepithelial neoplasia and intraductal papillary-mucinous neoplasms: Interobserver agreement. Pancreas 2005;31:344-349.
2. Murakami Y, Uemura K, Ohge H, et al.: Intraductal papillary-mucinous neoplasms and mucinous cystic neoplasms of the pancreas differentiated by ovarian-type stroma. Surgery 2006;140:448-453.
3. Tanaka M, Chari S, Adsay V, et al.: International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology 2006;6:17-32.
4. Klöppel G, Hurban RH, Longnecker DS, et al.: Ductal adenocarcinoma of the pancreas (Chapter 10). In: Hamilton SR, Aaltonen LA, editors. World Health Organization Classification of Tumours, Pathology and Genetics of Tumours of the Digestive System. Lyon: IARC Press; 2000. pp. 220-230.
5. Salvia R, Fernandez-del Castillo C, Bassi C, et al.: Main-duct intraductal papillary mucinous neoplasms of the pancreas: Clinical predictors of malignancy and long-term survival following resection. Ann Surg 2004; 678-685; discussion 685-677.
6. Shimada K, Sakamoto Y, Sano T, et al.: Invasive carcinoma originating in an intraductal papillary mucinous neoplasm of the pancreas: A clinicopathologic comparison with a common type of invasive ductal carcinoma. Pancreas 2006;32:281-287.
7. Heitz P, Komminoth P, Perren A, et al.: Tumours of the endocrine pancreas (Chapter 4). In: DeLellis RA, Lloyd RV, Heitz PhU, Eng C, editors. World Health Organization Classification of Tumours, Pathology and Genetics. Tumours of Endocrine Organs. Lyon: IARC Press; 2004. pp. 176-208.
8. Klimstra DS, Rosai J, Heffess CS: Mixed acinar-endocrine carcinomas of the pancreas. Am J Surg Pathol 1994;18:765-778.
9. Ohike N, Jurgensen A, Pipeleers-Marichal M, et al.: Mixed ductal-endocrine carcinomas of the pancreas and ductal adenocarcinomas with scattered endocrine cells: Characterization of the endocrine cells. Virchows Arch 2003;442:258-265.
10. van Eeden S, de Leng WW, Offerhaus GJ, et al.: Ductuloinsular tumors of the pancreas: Endocrine tumors with entrapped nonneoplastic ductules. Am J Surg Pathol 2004;28:813-820.
11. Hiyama E, Kodama T, Shinbara K, et al.: Telomerase activity is detected in pancreatic cancer but not in benign tumors. Cancer Res 1997;57:326-331.
12. Ohuchida K, Mizumoto K, Ogura Y, et al.: Quantitative assessment of telomerase activity and human telomerase reverse transcriptase messenger RNA levels in pancreatic juice samples for the diagnosis of pancreatic cancer. Clin Cancer Res 2005;11:2285-2292.
13. Hiyama E, Yamaoka H, Matsunaga T, et al.: High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma. Br J Cancer 2004;91:972-979.
14. Hiyama E, Yokoyama T, Tatsumoto N, et al.: Telomerase activity in gastric cancer. Cancer Res 1995;55:3258-3262.
15. Hiyama E, Hiyama K, Yokoyama T, et al.: Immunohistochemical detection of telomerase (hTERT) protein in human cancer tissues and a subset of cells in normal tissues. Neoplasia 2001;3:17-26.
16. Terris B, Dubois S, Buisine MP, et al.: Mucin gene expression in intraductal papillary-mucinous pancreatic tumours and related lesions. J Pathol 2002;197:632-637.
17. Adsay NV, Merati K, Basturk O, et al.: Pathologically and biologically distinct types of epithelium in intraductal papillary mucinous neoplasms: Delineation of an "intestinal" pathway of carcinogenesis in the pancreas. Am J Surg Pathol 2004;28:839-848.
18. Yonezawa S, Sato E: Expression of mucin antigens in human cancers and its relationship with malignancy potential. Pathol Int 1997;47:813-830.
19. Marrache F, Cazals-Hatem D, Kianmanesh R, et al.: Endocrine tumor and intraductal papillary mucinous neoplasm of the pancreas: A fortuitous association? Pancreas 2005;31:79-83.
20. Yamaguchi K, Ohuchida J, Ohtsuka T, et al.: Intraductal papillary-mucinous tumor of the pancreas concomitant with ductal carcinoma of the pancreas. Pancreatology 2002;2:484-490.
21. Deshpande V, Selig MK, Nielsen GP, et al.: Ductulo-insular pancreatic endocrine neoplasms: Clinicopathologic analysis of a unique subtype of pancreatic endocrine neoplasms. Am J Surg Pathol 2003;27:461-468.
22. Regitnig P, Spuller E, Denk H: Insulinoma of the pancreas with insular-ductular differentiation in its liver metastasis - Indication of a common stem-cell origin of the exocrine and endocrine components. Virchows Arch 2001;438:624-628.
23. Terada T, Kawaguchi M, Furukawa K, et al.: Minute mixed ductal-endocrine carcinoma of the pancreas with predominant intraductal growth. Pathol Int 2002;52:740-746.
24. Kamisawa T, Tu Y, Egawa N, et al.: Ductal and acinar differentiation in pancreatic endocrine tumors. Dig Dis Sci 2002;47:2254-2261.
25. Lüttges J, Zamboni G, Longnecker D, et al.: The immunohistochemical mucin expression pattern distinguishes different types of intraductal papillary mucinous neoplasms of the pancreas and determines their relationship to mucinous noncystic carcinoma and ductal adenocarcinoma. Am J Surg Pathol 2001;25:942-948.
26. Yamasaki H, Ikeda S, Okajima M, et al.: Expression and localization of MUC1, MUC2, MUC5AC and small intestinal mucin antigen in pancreatic tumors. Int J Oncol 2004;24:107-113.
27. Rooman I, Lardon J, Flamez D, et al.: Mitogenic effect of gastrin and expression of gastrin receptors in duct-like cells of rat pancreas. Gastroenterology 2001;121:940-949.